Clinical Oncology Next Generation Sequencing Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Application, By Technology, By Workflow, By End-use, By Country, & By Region

  • Report Id: HCDHR 2159
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Clinical Oncology Next Generation Sequencing Market Report Overview

Clinical oncology next generation sequencing market garnered a revenue of USD 739.3 million in the year 2019 globally and has been foreseen to yield USD 1,973.5 million by the year 2027 at a compound annual growth (CAGR) of 15.3% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Clinical Oncology Next Generation Sequencing market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Clinical Oncology Next Generation Sequencing Total Available Market (TAM)Size
  • Clinical Oncology Next Generation Sequencing Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Clinical Oncology Next Generation Sequencing Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Clinical Oncology Next Generation Sequencing Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Clinical Oncology Next Generation Sequencing Market: Application Insights
4.1. Global Application Historic Market Data & Future Forecasts, 2016-2027
4.2. Screening
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Sporadic Cancer
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Inherited Cancer
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Companion Diagnostics
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Clinical Oncology Next Generation Sequencing Market: Technology Insights
5.1. Global Technology Historic Market Data & Future Forecasts, 2016-2027
5.2. Whole Genome Sequencing
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Whole Exome Sequencing
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.4. Targeted Sequencing & Resequencing
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Clinical Oncology Next Generation Sequencing Market: Workflow Insights
6.1. Global Workflow Historic Market Data & Future Forecasts, 2016-2027
6.2. NGS Pre-Sequencing
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
6.3. NGS Sequencing
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
6.4. NGS Data Analysis
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 7. Clinical Oncology Next Generation Sequencing Market: End-use Insights
7.1. Global End-use Historic Market Data & Future Forecasts, 2016-2027
7.2. Hospitals
7.2.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
7.3. Clinics
7.3.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
7.4. Laboratories
7.4.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 8. Clinical Oncology Next Generation Sequencing Market: Regional Insights
8.1. Global Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Region 2016-2027
8.2. North America
8.2.1. Historic Market Data & Future Forecasts, 2016-2027
8.2.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.2.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.2.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.2.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.2.6. U.S.
8.2.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.2.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.2.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.2.6.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.2.6.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.2.7. Canada
8.2.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.2.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.2.7.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.2.7.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.2.7.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.3. Europe
8.3.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.3.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.3.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.3.6. U.K.
8.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.3.6.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.3.6.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.3.7. Germany
8.3.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.7.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.3.7.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.3.7.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.3.8. France
8.3.8.1. Historic Market Data & Future Forecasts, 2016-2027
8.3.8.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.3.8.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.3.8.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.3.8.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.4. Asia Pacific
8.4.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.4.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.4.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.4.6. China
8.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.4.6.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.4.6.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.4.7. India
8.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.7.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.4.7.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.4.7.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.4.8. Japan
8.4.8.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.8.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.8.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.4.8.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.4.8.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.4.9. South Korea
8.4.9.1. Historic Market Data & Future Forecasts, 2016-2027
8.4.9.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.4.9.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.4.9.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.4.9.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.5. Latin America
8.5.1. Historic Market Data & Future Forecasts, 2016-2027
8.5.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.5.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.5.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.5.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.5.6. Brazil
8.5.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.5.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.5.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.5.6.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.5.6.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.5.7. Mexico
8.5.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.5.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.5.7.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.5.7.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.5.7.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.6. Middle East & Africa
8.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.6.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.6.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.6.6. UAE
8.6.6.1. Historic Market Data & Future Forecasts, 2016-2027
8.6.6.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.6.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.6.6.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.6.6.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
8.6.7. South Africa
8.6.7.1. Historic Market Data & Future Forecasts, 2016-2027
8.6.7.2. Historic Market Data & Future Forecasts, By Application, 2016-2027
8.6.7.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
8.6.7.4. Historic Market Data & Future Forecasts, By Workflow, 2016-2027
8.6.7.5. Historic Market Data & Future Forecasts, By End-use, 2016-2027
Chapter 9. Company Profiles
9.1. Myriad Genetics, Inc.
9.1.1. Company Description
9.1.2. Financial Highlights
9.1.3. Product Portfolio
9.1.4. Strategic Initiatives
9.2. Thermo Fisher Scientific Inc.
9.2.1. Company Description
9.2.2. Financial Highlights
9.2.3. Product Portfolio
9.2.4. Strategic Initiatives
9.3. Agilent Technologies
9.3.1. Company Description
9.3.2. Financial Highlights
9.3.3. Product Portfolio
9.3.4. Strategic Initiatives
9.4. Hoffmann-La Roche Ltd
9.4.1. Company Description
9.4.2. Financial Highlights
9.4.3. Product Portfolio
9.4.4. Strategic Initiatives
9.5. Illumina, Inc.
9.5.1. Company Description
9.5.2. Financial Highlights
9.5.3. Product Portfolio
9.5.4. Strategic Initiatives
9.6. Partek, Inc.
9.6.1. Company Description
9.6.2. Financial Highlights
9.6.3. Product Portfolio
9.6.4. Strategic Initiatives
9.7. Pacific Bioscience, Inc.
9.7.1. Company Description
9.7.2. Financial Highlights
9.7.3. Product Portfolio
9.7.4. Strategic Initiatives
9.8. Perkin Elmer, Inc.
9.8.1. Company Description
9.8.2. Financial Highlights
9.8.3. Product Portfolio
9.8.4. Strategic Initiatives
9.9. Qiagen NV
9.9.1. Company Description
9.9.2. Financial Highlights
9.9.3. Product Portfolio
9.9.4. Strategic Initiatives
9.10. Beijing Genomics Institute (BGI)
9.10.1. Company Description
9.10.2. Financial Highlights
9.10.3. Product Portfolio
9.10.4. Strategic Initiatives

List of Tables
Table 1 Clinical Oncology Next Generation Sequencing MarketMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 2 Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Region, 2016-2027 (USD Million)
Table 3 Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 4 Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 5 Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 6 Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 7 ScreeningMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 8 Sporadic CancerMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 9 Inherited CancerMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 10 Companion Diagnostics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 11 OthersMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 12 Whole Genome SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 13 Whole Exome Sequencing Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 14 Whole Exome Sequencing Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 15 NGS Pre-SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 16 NGS SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 17 NGS Data AnalysisMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 18 HospitalsMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 19 ClinicsMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 20 LaboratoriesMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 21 North America Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 22 North America Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 23 North America Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 24 North America Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 25 North America Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 26 U.S. Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 27 U.S. Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 28 U.S. Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 29 U.S. Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 30 U.S. Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 31 Canada Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 32 Canada Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 33 Canada Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 34 Canada Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 35 Canada Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 36 Europe Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 37 Europe Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 38 Europe Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 39 Europe Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 40 Europe Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 41 U.K. Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 42 U.K Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 43 U.K Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 44 U.K Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 45 U.K Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 46 Germany Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 47 Germany Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 48 Germany Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 49 Germany Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 50 Germany Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 51 France Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 52 France Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 53 France nada Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 54 France Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 55 France Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 56 Asia Pacific Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 57 Asia Pacific Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 58 Asia Pacific Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 59 Asia Pacific Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 60 Asia Pacific Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 61 China Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 62 China Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 63 China Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 64 China Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 65 China Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 66 India Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 67 India Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 68 India Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 69 India Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 70 India Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 71 Japan Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 72 Japan Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 73 Japan Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 74 Japan Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 75 Japan Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 76 South Korea Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 77 South Korea Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 78 South Korea Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 79 South Korea Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 80 South Korea Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 81 Latin America Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 82 Latin America Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 83 Latin America Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 84 Latin America Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 85 Latin America Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 86 Brazil Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 87 Brazil Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 88 Brazil Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 89 Brazil Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 90 Brazil Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 91 Mexico Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 92 Mexico Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 93 Mexico Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 94 Mexico Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 95 Mexico Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 96 Middle East & Africa Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 97 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 98 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 99 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 100 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 101 UAE Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 102 UAE Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 103 UAE Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 104 UAE Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 105 UAE Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)
Table 106 South Africa Clinical Oncology Next Generation SequencingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 107 South Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Application, 2016-2027 (USD Million)
Table 108 South Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Technology, 2016-2027 (USD Million)
Table 109 South Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By Workflow, 2016-2027 (USD Million)
Table 110 South Africa Clinical Oncology Next Generation Sequencing Market Data & Future Forecasts, By End-use, 2016-2027 (USD Million)

List of Figures
Fig.1 Data Analysis Model
Fig.2Clinical Oncology Next Generation Sequencing Market, by 2016-2027 (USD Million)
Fig.3Clinical Oncology Next Generation Sequencing Market Segmentation
Fig.4Supply chain analysis
Fig.5 Clinical Oncology Next Generation Sequencing Market Driver Anlaysis
Fig.6 Clinical Oncology Next Generation Sequencing Market Restraint Analysis
Fig.7 Clinical Oncology Next Generation Sequencing Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Clinical Oncology Next Generation Sequencing Market
Fig.10 Company Market Share Analysis, 2019

Clinical Oncology Next Generation Sequencing Market Segmentation:

Clinical Oncology Next Generation Sequencing Market, By Application (2016-2027)

  • Screening
  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Others

Clinical Oncology Next Generation Sequencing Market, By Technology (2016-2027)

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

Clinical Oncology Next Generation Sequencing Market, By Workflow (2016-2027)

  • NGS Pre-Sequencing
  • NGS Sequencing
  • NGS Data Analysis

Clinical Oncology Next Generation Sequencing Market, By End-use (2016-2027)

  • Hospitals
  • Clinics
  • Laboratories

Clinical Oncology Next Generation Sequencing Market, By Region (2016-2027)

  • North America
    • S.
    • Canada
  • Europe
    • K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Clinical Oncology Next Generation Sequencing Market:

  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Partek, Inc.
  • Pacific Bioscience, Inc.
  • Perkin Elmer, Inc.
  • Qiagen NV
  • Beijing Genomics Institute (BGI)

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.